πŸ‡ΊπŸ‡Έ FDA
Patent

US 9611244

Cyclic compounds

granted A61PA61P1/16A61P25/00

Quick answer

US patent 9611244 (Cyclic compounds) held by Takeda Pharmaceutical Company Limited expires Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Apr 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61P, A61P1/16, A61P25/00, A61P25/02, A61P29/00